Connect with us

Coronavirus Prevention & Treatment

Thai Government pharmaceutical organisation boosts production of key medicines

Anukul

Published 

 on 

Thai Government pharmaceutical organisation boosts production of key medicines | The Thaiger
PHOTO: prachachat.net
  • follow us in feedly

Dr Mukdavan Prakobvaitayakit, the deputy managing director of The Government Pharmaceutical Organisation says “the GPO has been increasing the amount of production for chronic disease medication by 50%. ”

This unexpected Covid-19 pandemic has hit the stockpile of 5 – 6 key medicines, which are being used in the treatment of Covid-19. In normal circumstances, GPO usually purchases raw materials and equipment to stock up for at least 6 months in advance or to slowly build up stocks for at least 2 – 3 months.

Hospitals have been dispensing six-month quotas for chronic patients to cut down on congestion and reduce the risk of the spread of the virus.

Since the start of the pandemic, which first hit Thailand towards the end of January, the GPO has continually adjusted its production plan to focus on essential medicines for chronic diseases. This is done by bringing forward the delivery of raw materials, the time of production by using high-speed automatic pill-filling machines from Germany, and finding alternate sources in the supply chain.

So far, the GPO has found sources in India for ‘Simvastatin’ (lipid-lowering medication) and has been able to increase its production capacity from 56 million tablets to 62 million tablets per month.

The GPO also has found sources in India for chemicals used in the production of ‘Amlodipine’ (to treat high-blood pressure and coronary diseases) which will enable the GPO to boost monthly production capacity from 50 million pills to 75 million.

With raw materials now sourced in India and China the GPO has also been able to boost its capacity for the production of…

  • Diabetes drug ‘Metformin’
  • High blood pressure drug ‘Losartan’
  • All 22 anti-retroviral drugs used mainly in HIV patients

Overall, the GPO is expected to increase its production capacity for essential drugs by about 30% this month and up to 50% from May onwards.

SOURCE: The Nation

Thai Government pharmaceutical organisation boosts production of key medicines | News by The Thaiger

BANNER: ejan.co

Keep in contact with The Thaiger by following our Facebook page.
Never miss out on future posts by following The Thaiger.



Read more headlines, reports & breaking news in Thailand. Or catch up on your Thailand news.

My name is Anukul, I a writer for the Thaiger, I specialise in translation articles and social media, and assisting with our video production. I previously worked at Phuket Gazette and attended BIS international school in Phuket.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Coronavirus Thailand

Government ramps up production of 5 anti-Covid-19 medicines, procurement of others

Jack Burton

Published

on

Government ramps up production of 5 anti-Covid-19 medicines, procurement of others | The Thaiger
PHOTO: La Prensa Latina

The Government Pharmaceutical Organisation is increasing production of five drugs used treat Covid-19 to ensure adequate stocks for all patients. A GPO spokesmansaid that excluding Favipiravir also known as Avigan, Thailand has five drugs to treat Covid-19, totalling 39.6 million tablets: there are 1.8 million tablets of Chloroquine, an anti-malarial drug; 30.6 million tablets of an antiretroviral drug containing Lopinavir and Ritonavir, used to treat HIV/AIDS; 1.9 million tablets of the antiretroviral drug Darunavir; 1.9 million tablets of Ritonavir and 3.4 million tablets of Azithromycin, an antibiotic used to treat bacterial infections. The spokesman says the GPO has expedited the purchase […]

Continue Reading

Coronavirus (Covid-19)

Experimental antiviral drug Remdesivir fails first clinical trial

Jack Burton

Published

on

Experimental antiviral drug Remdesivir fails first clinical trial | The Thaiger
PHOTO: The Edge Markets

Reports are emerging that the experimental antiviral drug Remdesivir, developed by the American pharmaceutical company Gilead Sciences, has failed in its first randomised clinical trial to treat Covid-19, according to draft documents accidentally published by the World Health Organization and seen by the Financial Times. Gilead disputed how the now deleted post characterised the findings, saying the data showed a “potential benefit.” Gilead originally developed Remdesivir as a treatment for the Ebola virus, where it showed promise at stopping the virus from replicating in clinical trials, but it was never approved. Numerous media report that researchers in China carried out […]

Continue Reading

Coronavirus (Covid-19)

Thailand imports chemicals from China to commence local production of antivirals

Anukul

Published

on

Thailand imports chemicals from China to commence local production of antivirals | The Thaiger
PHOTO: pattayamail.com

“We need to make sure we have at least 1 million pills of Favipiravir in store.” The Managing Director of Thailand’s Government Pharmaceutical Organisation Dr. Withoon Danwiboon says, “we have made contact with China to buy ‘Favipiravir’ (an antiviral drug) to start the production of the drugs locally as one of the treatments of Covid-19 virus in the country.” “We are awaiting for the antiviral delivery from China. They will arrive next week.” Favipiravir, sold under the brand name ‘Avigan’, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of […]

Continue Reading
Follow The Thaiger by email:

Trending